Reactive Formulation Applicator for Tunable Cross-Linking Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biocompatible reactive formulations for sealing and hemostasis lack flexibility in controlling cross-linking properties, limiting their ability to address multiple clinical needs during surgical procedures.
Innovation Solution
An applicator instrument that mixes and expresses biocompatible reactive formulations, allowing for the controlled mixing and dispensing of multiple fluid components, including a neutralizing buffer, to form a final mixture that can be adjusted for specific clinical needs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pre-determined cross-link density is used in biocompatible reactive formulations, then the product can address one specific clinical need (e.g., adhesive strength), but the user cannot adjust performance characteristics to address different clinical needs
Solution Approach 1:
The patent implements dynamic control of cross-linking by allowing users to adjust the ratio of reactive components (e.g., PEG-NHS to PEG-NH2) and control reaction conditions (pH, temperature, time) to achieve different cross-link densities. This transforms a static, pre-determined formulation into a dynamic system that can be tuned for different clinical applications.
Solution Approach 2:
The patent changes key parameters including component ratios, pH levels, temperature, and reaction time to control cross-linking degree. By varying these parameters, the formulation can achieve different mechanical properties and performance characteristics suitable for various clinical needs.
2Strength
If high cross-link density is used to achieve high mechanical strength for adhesives, then adhesive performance is improved, but water swellability decreases
Solution Approach 1:
The patent allows adjustment of cross-link density parameters to balance mechanical strength and water swellability. By controlling the ratio of cross-linking agents and reaction conditions, users can optimize the formulation for either high strength (adhesive applications) or high swellability (sealant applications) as needed.
3Reliability
If multiple separate products are used to address different clinical needs (adhesive, sealant, adhesion preventive, hemostatic agent), then each product can be optimized for its specific function, but the complexity of product selection and application increases
Solution Approach 1:
The patent creates a universal biocompatible reactive formulation that can perform multiple functions (adhesive, sealant, adhesion preventive, hemostatic agent) by adjusting formulation parameters. This single versatile product replaces multiple specialized products, simplifying product selection and application while maintaining function-specific performance.
4Productivity
If cross-linking is allowed to proceed without control, then the formulation rapidly solidifies, but the user loses ability to control the timing and degree of curing
Solution Approach 1:
The patent implements control mechanisms that allow users to monitor and adjust the cross-linking process in real-time. By controlling component ratios, pH, temperature, and adding the third component at specific stages, users can feedback-control the reaction to achieve desired timing and degree of curing.
Solution Approach 2:
The patent allows preliminary mixing of the first two reactive components without immediate cross-linking, enabling the formulation to remain workable during application. The cross-linking reaction is then initiated or accelerated at the desired time by adding the third component or adjusting conditions.
Data Source
AI summary
A system for dispensing a biocompatible reactive formulation includes a first chamber containing a first fluid having a first reactive component, a second chamber containing a second fluid having a second reactive component, and a third chamber containing a third fluid.